Stories
of
Hope
Download the latest issue of Lymphoma Today
Order free Booklets and Fact Sheets about Hodgkin and Non-Hodgkin Lymphoma
Order your free copies of Research in Focus today.
What you need to know
About Lymphoma
If you or a loved one has been diagnosed with lymphoma, the most common blood cancer and third most common cancer of childhood, the Lymphoma Research Foundation (LRF) is here to help. On this Web site you will find valuable information about the different types of lymphoma - Hodgkin lymphoma and non-Hodgkin lymphoma, diagnostic techniques your health care practitioners may use, and treatment options. Here you can also learn about the latest research findings and get help searching for clinical trials that relate to your condition. The Lymphoma Support Network can help you connect with a peer who is also living with lymphoma or you can find out how to volunteer at an LRF chapter near you. Start by learning more about lymphoma.
Lymphoma News and Features
Treatment Update on Cutaneous Lymphoma
This free teleconference featuring Steven Horwitz, MD and Lauren Pinter-Brown, MD will be held on December 16, 2008 from 1:30 PM - 2:30 PM ET. Register today!
Blood Cancer Experts Share Discoveries
The 50th Annual American Society of Hematology (ASH) Meeting begins this Friday. Learn more the meeting's purpose and how LRF plans to keep you informed.
Treatment Response Correlates with Gene Expression
A gene-based study can predict how patients with large B-cell lymphoma will respond to treatment.
Pralatrexate Granted Third Orphan Drug Designation
The U.S. Food and Drug Administration (FDA) granted Pralatrexate orphan drug designation for the treatment of patients with follicular lymphoma.
Diagnoses of Hodgkin and non-Hodgkin lymphoma on the Increase
While great strides have been made in lymphoma research, new study clearly reveals the need for further research.
Pralatrexate Granted Second Orphan Drug Designation
The U.S. Food and Drug Administration (FDA) granted Pralatrexate orphan drug designation for the treatment of patients with diffuse large B-cell lymphoma.
Universal Lymphoma Classification System Revised
LRF Scientific Advisory Board member Elaine Jaffe, MD contributes to new World Health Organization description of over 60 lymphoma sub-types. Technological advancements contribute to change.
Hope for the Holidays Campaign
As we enter the season of giving, please join hundreds of volunteers across the country who will honor or remember loved ones through the Lymphoma Research Foundation's (LRF) Hope for the Holidays Campaign.
Meet Those Aided by Your Donation
Find out how your contribution to our Patient Aid Program has and can give lymphoma patients Hope for the Holidays.
New Online Resources Available
LRF is pleased to announce the availability of five new video podcasts for young adults and 14 new webcasts for patients, survivors and loved ones.
Caring for the Young Adult Lymphoma Survivor
This webcast, presented at the 2008 Association of Oncology Social Work Conference, explores the unique needs of young adults diagnosed with lymphoma.
TREANDA Receives Second Indication in 2008
The US Food and Drug Administration (FDA) approved a second indication for bendamustine hydrochloride for injection (TREANDA) in the treatment of indolent B-cell non-Hodgkin lymphoma.
Mantle Cell, Follicular & CLL/SLL Challenge Grants
Help LRF advance research into mantle cell, follicular and CLL/SLL.
LRF Announces New Follicular Lymphoma E-Update
Sign up for our new electronic follicular lymphoma newsletter.
Clinical Trials
Get valuable information, find out how LRF's Helpline and Clinical Trials Information Service can help and read about Ed Epstein's personal experience with a vaccine clinical trial sponsored by the National Cancer Institute.
How You Can Make A Difference!
Directly help those struggling with the financial burden of lymphoma treatment
Take a Step and Find a Cure for Lymphoma by participating in one of our 15 Lymphomathons nationwide
Make a Difference while having a good time at one of our fundraising events
IRA Benefit Renewed Through 2009!
Good news for those 70½ or older with IRA's! The President has signed into law a two-year extension of the IRA Rollover provision.
